Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)
CUSIP: 00972G207
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, $0.000000005 par value
- Shares outstanding
- 94,284,567,045
- Total 13F shares
- 180,188
- Share change
- +5,446
- Total reported value
- $488,063
- Price per share
- $2.70
- Number of holders
- 10
- Value change
- +$56,787
- Number of buys
- 5
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 00972G207?
CUSIP 00972G207 identifies AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972G207:
Top shareholders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Omnia Family Wealth, LLC |
13F
|
Company |
0%
|
87,628
|
$163,426 | — | 31 Mar 2024 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0%
|
48,491
|
$90,436 | — | 31 Mar 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0%
|
23,643
|
$44,094 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
14,769
|
$28,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
150
|
$280 | — | 31 Mar 2024 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
50
|
$93 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
6
|
$11 | — | 31 Mar 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
5
|
$7 | — | 31 Mar 2024 | |
| Rachelle Suzanne Jacques |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
1,018,027,792
|
— | — | 26 Apr 2024 | |
| Wendy F. Dicicco |
3/4/5
|
Interim CFO |
—
class O/S missing
|
158,473,915
|
— | — | 01 May 2024 | |
| Donald A. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
25,000,000
mixed-class rows
|
— | — | 28 Jun 2024 | |
| Michael Grissinger |
3/4/5
|
Director |
—
mixed-class rows
|
25,000,000
mixed-class rows
|
— | — | 28 Jun 2024 | |
| Mohamed Wa'El Ahmed Hashad |
3/4/5
|
Director |
—
class O/S missing
|
5,000,000
|
— | — | 28 Jun 2024 |
Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) as of Q2 2024
As of 30 Jun 2024,
Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
180,188 shares.
The largest 10 holders included
Omnia Family Wealth, LLC, Cerity Partners LLC, Cresset Asset Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., MORGAN STANLEY, and Cornerstone Planning Group LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
8
Q2 2024 holders
10
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.